Literature DB >> 8513637

Progress in the management of tuboovarian abscesses.

H C Wiesenfeld1, R L Sweet.   

Abstract

The last 20 years have witnessed remarkable improvements in the treatment of tuboovarian abscesses. Gone are the days of significant mortality associated with ruptured and unruptured TOAs. Broad-spectrum antibiotics have enabled patients to be treated solely with medical therapy, avoiding the need for surgery. Operative intervention is still necessary in 25% of cases of unruptured TOAs, but the combination of conservative surgical procedures, such as unilateral salpingo-oophorectomy, and broad-spectrum antimicrobial agent therapy have reduced the need for total abdominal hysterectomy with bilateral salpingo-oophorectomy greatly. Although fertility after TOAs is compromised significantly, new advances in reproductive technology, including in vitro fertilization and donor egg transplantation, represent reproductive options for these women. Percutaneous drainage and laparoscopic treatment of TOAs are becoming popular treatment options, but prospective studies urgently are needed to assess their efficacy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513637     DOI: 10.1097/00003081-199306000-00022

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  13 in total

1.  Identification of sexually transmitted bacteria in tubo-ovarian abscesses through nucleic acid amplification.

Authors:  Rodrigue Dessein; Géraldine Giraudet; Laure Marceau; Eric Kipnis; Sébastien Galichet; Jean-Philippe Lucot; Karine Faure
Journal:  J Clin Microbiol       Date:  2014-10-29       Impact factor: 5.948

Review 2.  Microbiota and pelvic inflammatory disease.

Authors:  Harsha Sharma; Reshef Tal; Natalie A Clark; James H Segars
Journal:  Semin Reprod Med       Date:  2014-01-03       Impact factor: 1.303

Review 3.  MDCT of pelvic inflammatory disease: a review of the pathophysiology, gamut of imaging findings, and treatment.

Authors:  James Spain; Matthew Rheinboldt
Journal:  Emerg Radiol       Date:  2016-09-19

4.  The evaluation of risk factors for failed response to conservative treatment in tubo-ovarian abscesses.

Authors:  Mehmet Özgür Akkurt; Serenat Eris Yalçın; İltaç Akkurt; Burak Tatar; And Yavuz; Yakup Yalçın; Mehmet Akif Akgül; Fulya Kayıkçıoğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-11-02

5.  Tuboovarian abscesses: is size associated with duration of hospitalization & complications?

Authors:  Jason Dewitt; Angela Reining; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Obstet Gynecol Int       Date:  2010-05-24

6.  Ultrasound Diagnosis of Bilateral Tubo-ovarian Abscesses in the Emergency Department.

Authors:  Kristi Stanley; Daniela Morato; Mikaela Chilstrom
Journal:  West J Emerg Med       Date:  2013-11

7.  A Tuboovarian Abscess Associated with a Ruptured Spleen.

Authors:  Jennifer S Li; Johnathan Michael Sheele
Journal:  Case Rep Emerg Med       Date:  2016-01-24

8.  Etiology of persistent tubo-ovarian abscess in Nairobi, Kenya.

Authors:  Craig R Cohen; Lisa Gravelle; Samwel Symekher; Peter Waiyaki; Walter E Stamm; Julia A Kiehlbauch
Journal:  Infect Dis Obstet Gynecol       Date:  2003

9.  Emergency surgery for tubo-ovarian abscess identified extended-spectrum beta-lactamase-producing Escherichia coli: the first case presentation revealing causative bacteria.

Authors:  Teppei Tokumaru; Yasuo Shima; Takehiro Okabayashi; Kazutoshi Hayashi; Yorito Yamamoto; Kazuhide Ozaki; Jun Iwata
Journal:  Surg Case Rep       Date:  2015-08-15

10.  An extremely rare case of tubo-ovarian abscesses involving corynebacterium striatum as causative agent.

Authors:  Tetsuya Yamamoto; Tsuneaki Kenzaka; Shimpei Mizuki; Yuki Nakashima; Houu Kou; Motoyoshi Maruo; Hozuka Akita
Journal:  BMC Infect Dis       Date:  2016-09-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.